INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

Sied Kebir; Lazaros Lazaridis; Teresa Schmidt; Christoph Oster; Jonas Feldheim; Daniela Pierscianek; Martin Proescholdt; Peter Hau; Anca-Ligia Grosu; Dietmar Krex; Ulrich Sure; Bjoern Scheffler; Christoph Kleinschnitz; Christoph Poetgen; Martin Stuschke; Martin Glas

INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

Sied Kebir
, Lazaros Lazaridis
, Teresa Schmidt
, Christoph Oster
, Jonas Feldheim
, Daniela Pierscianek
, Martin Proescholdt
, Peter Hau
, Anca-Ligia Grosu
, Dietmar Krex
, Ulrich Sure
, Bjoern Scheffler
, Christoph Kleinschnitz
, Christoph Poetgen
, Martin Stuschke
, Martin Glas

Universitätsklinik für Neurologie

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	NEURO-ONCOLOGY
Publikationsstatus	Veröffentlicht - 2022

Andere Dateien und Links

https://publons.com/wos-op/publon/57590042/

Dieses zitieren

Kebir, S., Lazaridis, L., Schmidt, T., Oster, C., Feldheim, J., Pierscianek, D., Proescholdt, M., Hau, P., Grosu, A.-L., Krex, D., Sure, U., Scheffler, B., Kleinschnitz, C., Poetgen, C., Stuschke, M., & Glas, M. (2022). INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL. NEURO-ONCOLOGY.

@article{e1c6a12b3d7b4c2eaaa1aaaffe0f7908,

title = "INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL",

author = "Sied Kebir and Lazaros Lazaridis and Teresa Schmidt and Christoph Oster and Jonas Feldheim and Daniela Pierscianek and Martin Proescholdt and Peter Hau and Anca-Ligia Grosu and Dietmar Krex and Ulrich Sure and Bjoern Scheffler and Christoph Kleinschnitz and Christoph Poetgen and Martin Stuschke and Martin Glas",

year = "2022",

language = "English",

journal = "NEURO-ONCOLOGY",

issn = "1522-8517",

publisher = "Oxford Univ Press",

}

Kebir, S, Lazaridis, L, Schmidt, T, Oster, C, Feldheim, J, Pierscianek, D, Proescholdt, M, Hau, P, Grosu, A-L, Krex, D, Sure, U, Scheffler, B, Kleinschnitz, C, Poetgen, C, Stuschke, M & Glas, M 2022, 'INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL', NEURO-ONCOLOGY.

TY - JOUR

T1 - INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

AU - Kebir, Sied

AU - Lazaridis, Lazaros

AU - Schmidt, Teresa

AU - Oster, Christoph

AU - Feldheim, Jonas

AU - Pierscianek, Daniela

AU - Proescholdt, Martin

AU - Hau, Peter

AU - Grosu, Anca-Ligia

AU - Krex, Dietmar

AU - Sure, Ulrich

AU - Scheffler, Bjoern

AU - Kleinschnitz, Christoph

AU - Poetgen, Christoph

AU - Stuschke, Martin

AU - Glas, Martin

PY - 2022

Y1 - 2022

UR - https://publons.com/wos-op/publon/57590042/

M3 - Abstract (Journal)

SN - 1522-8517

JO - NEURO-ONCOLOGY

JF - NEURO-ONCOLOGY

ER -